- Cancer Drugs
- Diabetes Drugs
- Mental Illness Drugs
- Cardiovascular Disease Drugs
- Hypertension Drugs
- Inflammation Drugs
- Allergy Drugs
- Central Nervous System Drugs
- Neurology Drugs
- Asthma Drugs
- Hepatitis Drugs
- Arthritis Drugs
- Osteoporosis Drugs
- Tuberculosis Drugs
- Malaria Drugs
- Alzheimer Drugs
- Parkinson Disease Drugs
- HIV
- Multiple Sclerosis Drugs
- Autoimmune Drugs
- Insomnia Drugs
- Obesity Drugs
- Gaucher Drugs
- Anemia Drugs
- Crohn Drugs
- Huntington Drugs
- Paget Drugs
Diseases & treatment Market Research Reports
Title | published | price | |
---|---|---|---|
Global Erythropoietin Stimulating Agents Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "...... oglobin levels. Hemoglobin is the protein in red blood cells that helps blood carry oxygen throughout the body.
The report focuses on the Erythropoietin Stimulating Agents market size, segment size (mainly covering product type, applic......" | 01-Dec-2022 | $3450 | |
Global Edaravone Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "...... />
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers......" | 01-Dec-2022 | $3450 | |
Global Antacid Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "......
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, ......" | 01-Dec-2022 | $3450 | |
Global Stavudine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028By QYResearch Group "...... not a first-line treatment. It is given by mouth
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revise......" | 01-Dec-2022 | $5600 | |
Global Doxofylline Tablets Industry Research Report, Growth Trends and Competitive Analysis 2022-2028By QYResearch Group "...... gulations, market information and industry data. Data were collected from the Doxofylline Tablets manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party datab......" | 30-Nov-2022 | $5600 | |
Radiodermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... e Radiodermatitis (Toxicology) pipeline landscape.
Radiodermatitis is an inflammation of the skin caused by radiation. Several factors can be attributed to the varying response of patients' skin to radiation therapy such as treatment-rel......" | 30-Nov-2022 | $2000 | |
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... rtension (Cardiovascular) pipeline landscape.
Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. Many factors can affect blood pressure, including hormon......" | 30-Nov-2022 | $2500 | |
Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ew of the Myocardial Fibrosis (Cardiovascular) pipeline landscape.
Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal s......" | 30-Nov-2022 | $2000 | |
Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Encephalopathy (Central Nervous System) pipeline landscape.
Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, i......" | 30-Nov-2022 | $2000 | |
Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ment, 2022, provides an overview of the Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline landscape.
Metachromatic leukodystrophy is an inherited disorder characterized by the accumulation of fats called sulfatides in ......" | 30-Nov-2022 | $2000 | |
|